Refecoxib versus placebo ulcer rates.
Goldkind
L
L
D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects*; D007783:Lactones / Q000009:adverse effects*; D010437:Peptic Ulcer / Q000139:chemically induced*; D010919:Placebos / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D013450:Sulfones
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D010919:Placebos; D013450:Sulfones; C116926:rofecoxib